Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Azaya Therapeutics
Azaya Therapeutics develops nanotechnology for advanced cancer treatment.
Sector
Subsector
Location
Nanoligent
Nanoligent is a biotech company developing targeted-therapeutic biologics for diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Minerva Biotechnologies
Minerva Biotechnologies develops cancer immunotherapies and stem cell technologies for regenerative medicine.
Sector
Subsector
Location
total rounds
total raised
S.Biomedics
S.Biomedics is a company that develops somatic cell therapy for the safe treatment of intractable diseases.
Sector
Subsector
Keywords
Location
total rounds
Financials
Funding Rounds5
Number of Funding Rounds
Money Raised
Their latest funding was raised on 17.02.2022. Their latest round Venture - Series Unknown
CARB-X
CARB-X is a global non-profit partnership accelerating antibacterial R&D.
Sector
Subsector
Location
count Of Investments
count Of Exists
Co-Investors
Investors1
Number of lead investors
Number of investors
CARB-X
CARB-X is a global non-profit partnership accelerating antibacterial R&D.
Sector
Subsector
Location
count Of Investments
count Of Exists
Erin Duffy
Erin Duffy is an R&D Chief at CARB-X.
People
Founders1
Liangfang Zhang
Liangfang Zhang received his Ph.D. in Chemical & Biomolecular Engineering from the University of Illinois at Urbana-Champaign in 2006. He was a postdoctoral associate in the laboratory of Prof. Robert Langer at MIT during 2006-2008. He received his M.S. and B.E. degrees in Chemical Engineering from Tsinghua University in 2002 and 2000, respectively. He joined UC San Diego as an Assistant Professor in July 2008 and was promoted to an Associate Professor with tenure in March 2012 and to Professor in July 2014. Prof. Zhang has published 128 peer-reviewed articles and holds 43 issued/pending patents. He received the Victor K. LaMer Award from the American Chemistry Society in 2009, the Unilever Award from the American Chemistry Society in 2012, the MIT Technology Review’s TR35 Innovator Award in 2013, the Allan P. Colburn Award from the American Institute of Chemical Engineers in 2014, and was elected to the Fellow of the American Institute of Medical and Biological Engineering in 2015. Prof. Zhang was selected as one of The Brilliant 10 in all US science and engineering fields by the magazine Popular Science in 2016.
current job
organization founded
Liangfang Zhang